Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register
Authors:
- G.-R. BurmesterGBG.-R. Burmester
- C. WittCWC. Witt
- N. HunzelmannNHN. Hunzelmann
- E. GenthEGE. Genth
- T. KriegTKT. Krieg
- W. LehmacherWLW. Lehmacher
- I. MelchersIMI. Melchers
- M. MeurerMMM. Meurer
- U. Muller-LadnerUMU. Muller-Ladner
- E. Schulze-LohoffESE. Schulze-Lohoff
- M. BeckerMBM. Becker
Open Access
- 23 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (1) , 70-73
Abstract
Objectives. In SSc, diagnosis and classification is based mainly on skin sclerosis. Herein, we investigated in a large multicentre cohort, to what extent skin sclerosis reflects organ involvement and additional clinical symptoms. Methods. A total of 1200 SSc patients from the register of the German Systemic Sclerosis Network (DNSS), classified as either lcSSc or dcSSc, were analysed for their serological characteristics, clinical symptoms and organ manifestations in relation to skin involvement measured by the modified Rodnan skin score (mRSS). Results. SSc patients with different mRSS did not differ significantly in their disease duration and in most of the clinical symptoms. They showed a similar distribution of most organ manifestations such as pulmonary arterial hypertension as well as cardiac, renal and nervous system involvement. More severe skin thickening was found to be associated with pulmonary fibrosis and gastrointestinal symptoms, as well as with digital ulcers and musculoskeletal involvement. Conclusions. In patients with SSc, potentially life-threatening complications and clinical symptoms with high impact on the quality of life occur independently from the extent of skin sclerosis. The diagnosis in SSc patients with a low mRSS could be missed or they could be insufficiently treated.Keywords
This publication has 13 references indexed in Scilit:
- The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvementRheumatology, 2008
- Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosisAnnals of the Rheumatic Diseases, 2007
- The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosisAnnals of the Rheumatic Diseases, 2007
- Changes in causes of death in systemic sclerosis, 1972–2002Annals of the Rheumatic Diseases, 2007
- Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 2007
- Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192Arthritis & Rheumatism, 2007
- A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosisClinical Rheumatology, 2006
- Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseAnnals of the Rheumatic Diseases, 2001
- ORGAN MANIFESTATIONS IN 100 PATIENTS WITH PROGRESSIVE SYSTEMIC SCLEROSIS: A COMPARISON BETWEEN THE CREST SYNDROME AND DIFFUSE SCLERODERMARheumatology, 1989
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980